Skip to main content
SpringerLink
Log in

Updated American Urological Association Guidelines for the Management of Benign Prostatic Hyperplasia: Prostatic Artery Embolization Made it into the Guidelines!

  • Commentary
  • Embolisation (arterial)
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sandhu JS, Bixler BR, Dahm P, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment. J Urol. 2023. https://doi.org/10.1097/JU0000000000003698.

    Article  PubMed  Google Scholar 

  2. Carnevale FC, Antunes AA, da Motta Leal Filho JM, et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Interv Radiol. 2010;33:355–61.

    Article  Google Scholar 

  3. Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, Oliveira AG. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol. 2011;22:11–9.

    Article  PubMed  Google Scholar 

  4. McWilliams JP, Kuo MD, Rose SC, et al. Society of Interventional Radiology position statement: prostate artery embolization for treatment of benign disease of the prostate. J Vasc Interv Radiol. 2014;25:1349–51.

    Article  PubMed  Google Scholar 

  5. McWilliams JP, Bilhim TA, Carnevale FC, et al. Society of Interventional Radiology multisociety consensus position statement on prostatic artery embolization for treatment of lower urinary tract symptoms attributed to benign prostatic hyperplasia: from the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Société Française de Radiologie, and the British Society of Interventional Radiology. Endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology. J Vasc Interv Radiol. 2019;30:627–37.

    Article  PubMed  Google Scholar 

  6. Bilhim T, Costa NV, Torres D, Pinheiro LC, Spaepen E. Long-term outcome of prostatic artery embolization for patients with benign prostatic hyperplasia: single-centre retrospective study in 1072 patients over a 10-year period. Cardiovasc Interv Radiol. 2022;45:1324–36.

    Article  Google Scholar 

  7. Insausti I, Sáez de Ocáriz A, Galbete A, et al. Randomized comparison of prostatic artery embolization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia. J Vasc Interv Radiol. 2020;31:882–90.

    Article  PubMed  Google Scholar 

  8. Abt D, Mullhaupt G, Hechelhammer L, et al. Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label, single-centre trial. Eur Urol. 2021;80:34–42.

    Article  PubMed  Google Scholar 

  9. Pisco JM, Bilhim T, Costa NV, et al. Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia. Eur Urol. 2020;77:354–62.

    Article  PubMed  Google Scholar 

  10. Sapoval M, Thiounn N, Descazeaud A, et al. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial. Lancet Reg Health Eur. 2023;31:100672.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gravas S, Cornu JN, Gacci M, et al. EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), including benign prostatic obstruction (BPO). https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Management-of-Non-Neurogenic-Male-LUTS-2021.pdf

  12. Cornelis FH, Bilhim T, Hacking N, Sapoval M, Tapping CR, Carnevale FC. CIRSE standards of practice on prostatic artery embolisation. Cardiovasc Interv Radiol. 2020;43:176–85.

    Article  Google Scholar 

  13. https://www.nice.org.uk/guidance/ipg611

  14. Powell T, Rahman S, Staib L, Bhatia S, Ayyagari R. Operator learning curve for prostatic artery embolization and its impact on outcomes in 296 patients. Cardiovasc Interv Radiol. 2023;46:229–37.

    Article  Google Scholar 

  15. Wang C, Kuban JD, Lee SR, et al. Utilization of endovascular and surgical treatments for symptomatic uterine leiomyomas: a population health perspective. J Vasc Interv Radiol. 2020;31:1552–9.

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Interventional Radiology Unit, Centro Hospitalar Universitário de Lisboa Central (CHULC), SAMS Hospital, Lisbon, Portugal

    Tiago Bilhim

  2. David Geffen School of Medicine at UCLA, Los Angeles, USA

    Justin P. McWilliams

  3. Prostate Centers USA, 2755 Hartland Rd #110, Falls Church, VA, 22043, USA

    Sandeep Bagla

Authors
  1. Tiago Bilhim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Justin P. McWilliams
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandeep Bagla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tiago Bilhim.

Ethics declarations

Conflict of interest

TB is a paid consultant for Merit Medical and has received speaker fees for Philips Medical, Cook Medical, Terumo and is a stock holder for EmbolX. JPMW received lecture fees from Penumbra, Terumo, Johnson & Johnson, and Siemens Medical; consulting fees from Asahi Intecc. SB received consulting fees (Medtronic, CrannMed, Boston Scientific, Terumo, Guerbet, Varian); leadership (President & CEO Prostate Centers USA); stock (MBiotechnologies, Embolx).

Ethical Approval

Compliance with Ethical Standards statements: Institutional review board approval was not needed.

Consent for Publication

All authors had control of the publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bilhim, T., McWilliams, J.P. & Bagla, S. Updated American Urological Association Guidelines for the Management of Benign Prostatic Hyperplasia: Prostatic Artery Embolization Made it into the Guidelines!. Cardiovasc Intervent Radiol 47, 150–153 (2024). https://doi.org/10.1007/s00270-023-03617-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-023-03617-5

Search

Navigation